Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Changes in hippocampal matrix metalloproteinase-9 (MMP-9) and angiopoietin-2 (ANG-2) expression over time following bilateral common carotid artery.

Published byDamian Anderson Modified over 4 years ago

Similar presentations

Presentation on theme: "Fig. 1. Changes in hippocampal matrix metalloproteinase-9 (MMP-9) and angiopoietin-2 (ANG-2) expression over time following bilateral common carotid artery."— Presentation transcript:

1 Fig. 1. Changes in hippocampal matrix metalloproteinase-9 (MMP-9) and angiopoietin-2 (ANG-2) expression over time following bilateral common carotid artery occlusion (BCCAo). (A) Schematic diagram of experimental procedure. (B) Representative western blot for MMP-9 (n=4) and ANG-2 (n=5). (C) Hippocampal MMP-9 levels were significantly increased at 1 week following BCCAo, compared to controls (*). Increased MMP-9 returned to control levels at 4 and 8 weeks (#). (D) Hippocampal ANG-2 also increased at 1 week following BCCAo (*), although its expression levels decreased to control levels at 8 weeks following BCCAo (#, ##). Fig. 1. Changes in hippocampal matrix metalloproteinase-9 (MMP-9) and angiopoietin-2 (ANG-2) expression over time following bilateral common carotid artery occlusion (BCCAo). (A) Schematic diagram of experimental procedure. (B) Representative western blot for MMP-9 (n=4) and… Exp Neurobiol Aug;27(4):

Download ppt "Fig. 1. Changes in hippocampal matrix metalloproteinase-9 (MMP-9) and angiopoietin-2 (ANG-2) expression over time following bilateral common carotid artery."

Similar presentations

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
WEEK 1 You have 10 seconds to name…

WEEK 1 You have 10 seconds to name…
Effects of matrix metalloproteinase-9 on insulin survival pathways in Alzheimer’s disease Introduction Defective brain insulin signaling has been suggested.

Effects of matrix metalloproteinase-9 on insulin survival pathways in Alzheimer’s disease Introduction Defective brain insulin signaling has been suggested.
Fig. 2. The expression of pKr-2 in the substantia nigra (SN) of patients with Parkinson's disease (PD). (A, B) Western blot analysis for pKr-1-2 and pKr-2,

Fig. 2. The expression of pKr-2 in the substantia nigra (SN) of patients with Parkinson's disease (PD). (A, B) Western blot analysis for pKr-1-2 and pKr-2,
Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.

Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.

Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.
Fig. 2. Neuroprotective effects of ex-4 through the G protein-coupled GLP-1 receptor. (A) Infarct volume was assessed by TTC staining after tMCAO in rats.

Fig. 2. Neuroprotective effects of ex-4 through the G protein-coupled GLP-1 receptor. (A) Infarct volume was assessed by TTC staining after tMCAO in rats.
Fig. 4. TGF-α is one of the major cytokines in M2 conditioned media

Fig. 4. TGF-α is one of the major cytokines in M2 conditioned media
Fig. 1. A diagram of optical recording of intrinsic signal (ORIS) imaging in the MCAO model. (A) The middle cerebral artery occlusion (MCAO) was performed.

Fig. 1. A diagram of optical recording of intrinsic signal (ORIS) imaging in the MCAO model. (A) The middle cerebral artery occlusion (MCAO) was performed.
Fig. 2. Effects of Ang II on the p130Cas protein assayed by Western blotting. (A) The bands for p130Cas protein at 130 kDa are reduced by 10-7 M Ang II.

Fig. 2. Effects of Ang II on the p130Cas protein assayed by Western blotting. (A) The bands for p130Cas protein at 130 kDa are reduced by 10-7 M Ang II.
Fig. 5. The measurement of phosphorylation of p53 level in N2A cells under high glucose condition and agmatine treatment. (A, B) p53 phosphorylation levels.

Fig. 5. The measurement of phosphorylation of p53 level in N2A cells under high glucose condition and agmatine treatment. (A, B) p53 phosphorylation levels.
Fig. 1. Infarct size and behavioral outcomes in response to single and repeated treatment of hUCB-MSCs after MCAO. (A) Schematic of the time schedule.

Fig. 1. Infarct size and behavioral outcomes in response to single and repeated treatment of hUCB-MSCs after MCAO. (A) Schematic of the time schedule.
Fig. 9. Treatment of flagellin increased cell survival in hypoxic conditions. (A) After 2 h OGD, cell cytotoxicity levels were measured by a LDH assay.

Fig. 9. Treatment of flagellin increased cell survival in hypoxic conditions. (A) After 2 h OGD, cell cytotoxicity levels were measured by a LDH assay.
Fig. 2. Severities of seizures by durations and daily frequency at different time points. (A) An example of seizure activity in EEG recording. (B) Seizure.

Fig. 2. Severities of seizures by durations and daily frequency at different time points. (A) An example of seizure activity in EEG recording. (B) Seizure.
Fig. 6. Akt inhibitor IV reduced the activity of the NF-κB promoter in postconditioning. NF-κB activity was detected by a reporter gene assay in bEnd.3.

Fig. 6. Akt inhibitor IV reduced the activity of the NF-κB promoter in postconditioning. NF-κB activity was detected by a reporter gene assay in bEnd.3.
Fig. 2. Development and validation of shRNAs for SOCE components

Fig. 2. Development and validation of shRNAs for SOCE components
Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the.

Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the.
Heregulin, Cysteine Rich-61 and Matrix Metalloproteinase 9 Expression in Human Carotid Atherosclerotic Plaques: Relationship with Clinical Data  F. Sigala,

Heregulin, Cysteine Rich-61 and Matrix Metalloproteinase 9 Expression in Human Carotid Atherosclerotic Plaques: Relationship with Clinical Data  F. Sigala,
Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure  Oscar.

Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure  Oscar.
Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts  Irvin Mayers, MD, Thomas Hurst, MVSc, Lakshmi.

Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts  Irvin Mayers, MD, Thomas Hurst, MVSc, Lakshmi.

Similar presentations

Ads by Google